Lidings Bolsters its Tax and Customs Practice With Hire of the New Counsel
Lidings is pleased to announce Dmitry Kirillov joining the Firm as counsel in Tax and Customs practice.
Lidings is pleased to announce Dmitry Kirillov joining the Firm as counsel in Tax and Customs practice.
Lidings Intellectual Property practice lawyers have set a precedent in a dispute concerning patent extension.
Best Lawyers, an international legal directory annually identifying the most prominent lawyers around the world by analyzing their professional skills and achievements during the year, once again lists Lidings’ experts among the best lawyers in Russia.
During a lengthy five-year bankruptcy of the pharmaceutical distributor Grama LLC, the bankruptcy manager challenged transactions with suppliers - large international pharmaceutical companies. Worst-hit was AstraZeneca Pharmaceuticals obliged to return the bankrupt distributor 266 million rubles. Lidings represents the company since 2019.
Lidings demonstrates new achievements and takes advanced positions in the rating of the leading legal advisors in Russia based on the analytical research held annually by the “Kommersant” newspaper. Results of the new research published in a special supplement to Kommersant as of March 17, 2021.
March 11, 2021 Pravo.ru-300 released its individual rating of lawyers. Based on the new rating Lidings managing partner Andrey Zelenin, partners Stepan Guzey and Alexander Popleyuk take top positions in key practice areas.
Chambers and Partners Europe has announced the results of its annual research of the leading legal advisors. Lidings is traditionally highly recommended for Dispute Resolution, Corporate and M&A, and Life Sciences advice in Russia.
Ritz Carlton Moscow, December 5th 2019. The results of the annual Pravo.ru-300 law firms’ ranking were announced at an awarding ceremony at the Ritz Carlton Moscow.
The Russian pharmaceutical industry has recently become the field for serious patent-related battles between large foreign producers of original drugs and Russian manufacturers of generics.
We use cookies to generate statistics which helps us optimize the site for each user. By clicking “I AGREE” you agree to the use of cookies. For more information, see the Privacy and Data Protection Policy. If you do not accept the terms of cookie processing, please leave the site